EICHORCondition: Spinal Cord Injuries · Urinary Diversion · Neurogenic Bladder · Sponsor: Centre Hospitalier Universitaire de Nīmes
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
Continent Cutaneous Urinary Deviation (CUD), using the Mitrofanoff, Yang-Monti or Casale principle, is offered to patients with neurological diseases who are unable to perform intermittent catheterisation through the native urethra due to upper limb disability. There is very little data in the literature examining the long-term efficacy and complications of this technique. The main objective of this study is to evaluate the effectiveness of long-term CUDs in spinal cord injury patients. The secondary objectives are to evaluate the surgical complications and the impact on the patient's quality of life. For each patient, several data will be collected and analyzed: age at operation, sex, Body Mass Index (BMI), ASA score, ASIA score, type of bladder dysfunction assessed by urodynamic evaluation, urinary abnormalities assessed by morphological examination (ultrasound and / or computed tomography) and cystoscopy, creatinine clearance, operative indications, initial mictional mode, surgical assembly and any immediate or late complications. In a second stage, a questionnaire survey will be conducted by telephone.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: Specific inclusion criteria for the study : * no history of continuous cystostomy in another centre * a follow-up \> 24 months, * a continent cutaneous urinary diversion for a spinal cord injury. General inclusion criteria : * Patient affiliated to or beneficiary of a health insurance scheme. * Adult patient (≥18 years of age) and under 85 years of age. Exclusion Criteria: * Criteria for non-inclusion specific to the study : * All urinary incontinence outside of medullary waiting period. * A history of continuous cystostomy in another centre. * A follow-up of less than 24 months, * a continent cutaneous urinary diversion for a neurological pathology other than spinal cord injury. General criteria for non-inclusion : * Patient in a period of exclusion determined by another study. * Patient for whom it is impossible to give enlightened information. * Patient under legal protection, guardianship or curatorship. * Patient unable to express consent
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Nîmes University Hospital | Nîmes, Gard, France | — |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04936217